Lisa Nodzon, PhD, ARNP, AOCNP, on CLL: Measuring Residual Disease

Lisa Nodzon, PhD, ARNP, AOCNP, of Moffitt Cancer Center, discusses the progress made in treating chronic lymphocytic leukemia, the clinical implications of undetectable minimal residual disease in blood and bone marrow, and how advanced practitioners can help patients better understand their disease to weigh their treatment options.